Jaume Martial, Laffont Sophie, Chapey Emmanuelle, Blanpied Catherine, Dietrich Gilles
INSERM, U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France.
J Neuroimmunol. 2007 Aug;188(1-2):95-102. doi: 10.1016/j.jneuroim.2007.06.013. Epub 2007 Jul 6.
A number of studies have been dedicated to estimate the consequences on immunity of the clinical use of opioids by focusing on mitogen-induced polyclonal proliferation of T cells from blood or spleen. Here we examined, under physiological conditions, the contribution of endogenous opioids in the development of a CD4(+) T cell response within draining lymph nodes. We show in OVA-primed DO11.10 mice that delta-opioid receptors were up-regulated upon T cell activation in vivo and that opioid receptor neutralization increased the number of specific anti-OVA T lymphocytes without promoting their capacity to proliferate. The sensitivity to Fas-mediated apoptosis of T lymphocytes and the synthesis of homeostatic lymphoid chemokines were not either affected suggesting that opioids operate mainly before the entry of T lymphocytes into lymph nodes.
许多研究致力于通过关注丝裂原诱导的血液或脾脏T细胞多克隆增殖来评估阿片类药物临床使用对免疫的影响。在此,我们在生理条件下研究了内源性阿片类物质在引流淋巴结内CD4(+) T细胞反应发展中的作用。我们在卵清蛋白(OVA)致敏的DO11.10小鼠中发现,δ-阿片受体在体内T细胞激活后上调,并且阿片受体中和增加了特异性抗OVA T淋巴细胞的数量,但未促进其增殖能力。T淋巴细胞对Fas介导的凋亡的敏感性和稳态淋巴细胞趋化因子的合成也未受影响,这表明阿片类药物主要在T淋巴细胞进入淋巴结之前起作用。